Article Details
Retrieved on: 2024-10-18 06:10:23
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the impacts of COVID-19 vaccines on patients with inflammatory rheumatic diseases (I-RMDs), highlighting flare risks related to different vaccines, including Pfizer-BioNTech and AstraZeneca. Key factors include vaccine types, disease activity, and anti-rheumatic drug use.
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here